Yankuo Liu
Xiamen, 361101, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10.
Journal: Cell communication and signaling : CCS
Published: June 12, 2024
Discovery of a small-molecule NDR1 agonist for prostate cancer therapy.
Journal: Frontiers in pharmacology
Published: January 08, 2024
Targeting the hedgehog pathway in MET mutation cancers and its effects on cells associated with cancer development.
Journal: Cell communication and signaling : CCS
Published: July 21, 2023
TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1.
Journal: iScience
Published: March 26, 2023
Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.
Journal: Frontiers in immunology
Published: February 22, 2023
Branched-chain keto-acid dehydrogenase kinase regulates vascular permeability and angiogenesis to facilitate tumor metastasis in renal cell carcinoma.
Journal: Cancer science
Published: February 15, 2023
BCKDK regulates breast cancer cell adhesion and tumor metastasis by inhibiting TRIM21 ubiquitinate talin1.
Journal: Cell death & disease
Published: November 14, 2022
Insights into prognosis and immune infiltration of cuproptosis-related genes in breast cancer.
Journal: Frontiers in immunology
Published: September 26, 2022
The Crucial Role of AR-V7 in Enzalutamide-Resistance of Castration-Resistant Prostate Cancer.
Journal: Cancers
Published: August 31, 2022
Prognostic and Immunological Role of STK38 across Cancers: Friend or Foe?
Journal: International journal of molecular sciences
Published: August 22, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026